All In Biotech

Drug Trial Radar · NCT00975143

Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne

A Double-Blind, Randomized, Phase III, Parallel Group Study Evaluating the Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne

Last checked: Nov 20, 2026Latest source record: Jul 4, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 925 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

925

Actual

Start

Sep 2009

Primary completion

May 2011

Study completion May 2011

Sponsor

Lead sponsor
Cipher Pharmaceuticals Inc.Industry
Sponsor type
Industry
First posted
Sep 11, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 12 years, up to 54 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the efficacy and safety of CIP-Isotretinoin and a marketed (generic) formulation of isotretinoin when both are administered twice daily with meals.

Conditions

  • Severe Nodular Acne

Interventions

  • CIP-IsotretinoinDrug

    0.5 mg/kg/day for 4 weeks, and 1 mg/kg/day for 16 weeks, taken orally, twice daily.

  • IsotretinoinDrug

    0.5 mg/kg/day for 4 weeks, and 1 mg/kg/day for 16 weeks, taken orally, twice daily.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Co-primary Outcome 1: Change From Baseline in Total Nodular Lesion Count (Facial and Truncal)Time frame: 20 weeks
  2. Co-Primary Outcome 2: Proportion of Patients Who Achieve at Least a 90% Reduction in Total Number of Nodular Lesions (Facial and Truncal).Time frame: 20 weeks

Locations

49 sites in 2 countries. Site status is shown where the registry gives one.

  • Total Skin & Beauty Dermatology Center

    Birmingham, Alabama

  • Burke Pharmaceutical Research

    Hot Springs, Arkansas

  • Center for Dermatology Clinical Research

    Fremont, California

  • Dermatology Research Associates

    Los Angeles, California

  • Dermatology Specialists

    Oceanside, California

  • Skin Surgery Medical Group, Inc.

    San Diego, California

  • Horizons Clinical Research Center

    Denver, Colorado

  • North Florida Dermatology Associates, PA

    Jacksonville, Florida

  • Ameriderm Research

    Jacksonville, Florida

  • Park Avenue Dermatology

    Orange Park, Florida

  • Ameriderm Research

    Ormond Beach, Florida

  • Peachtree Dermatology Associates, PC

    Atlanta, Georgia

  • MedaPhase Inc.

    Newnan, Georgia

  • Northwest Clinical Trials

    Boise, Idaho

  • Northwest Clinical Trials

    Nampa, Idaho

  • Dawes Fretzin Clinical Research

    Indianapolis, Indiana

  • The Indiana Clinical Trials Center, PC

    Plainfield, Indiana

  • The South Bend Clinic, LLP

    South Bend, Indiana

  • Dermatology and Skin Cancer Specialists / Pediaresearch, LLC

    Owensboro, Kentucky

  • ActivMed Practices & Research

    Haverhill, Massachusetts

  • Great Lakes Research Group

    Bay City, Michigan

  • Hamzavi Dermatology

    Fort Gratiot, Michigan

  • Minnesota Clinical Study Center

    Fridley, Minnesota

  • Skin Specialists, PC

    Omaha, Nebraska

  • Comprehensive Clinical Research

    Berlin, New Jersey

  • Haber Dermatology, Clinical Research Center

    South Euclid, Ohio

  • Oregon Dermatology and Research Center

    Portland, Oregon

  • Paddington Testing Company Inc.

    Philadelphia, Pennsylvania

  • Radiant Research, Inc.

    Greer, South Carolina

  • Dermatology Associates of Knoxville

    Knoxville, Tennessee

  • Tennessee Clinical Research Center

    Nashville, Tennessee

  • Arlington Center for Dermatology

    Arlington, Texas

  • Suzanne Bruce and Associates - The Center for Skin Research

    Houston, Texas

  • Progressive Clinical Research

    San Antonio, Texas

  • Stephen Miller, MD, PA Dermatology

    San Antonio, Texas

  • Dermatology Research Center

    Salt Lake City, Utah

  • Premier Clinical Research

    Spokane, Washington

  • Derm Research @ 888 Inc.

    Vancouver, British Columbia, Canada

  • Dermadvances Research

    Winnipeg, Manitoba, Canada

  • Durondel C.P. Inc

    Moncton, New Brunswick, Canada

Showing 40 of 49 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.